Atherosclerosis
Volume 204, Issue 1 , Pages 1-10 , May 2009

Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm

  • Kevin R. Bainey
    • ,
  • Bodh I. Jugdutt

      Affiliations

    • Corresponding Author InformationCorresponding author at: 2C2 Walter MacKenzie Health Sciences Centre, Division of Cardiology, University of Alberta and Hospitals, 8440-112 Street, Edmonton, Alberta, T6G 2B7 Canada. Tel.: +1 780 439 0745; fax: +1 780 437 3546.

Received 26 June 2008 ,Revised 30 August 2008 ,Accepted 16 September 2008.

References 

  1. American Heart Association. Heart disease and stroke statistics-2006 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113:e85–151.
  2. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart. 2002;88:119–124
  3. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians of European, South-Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ. 1999;161:132–138
  4. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. I. General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;04:2746–2753
  5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104:2855–2864
  6. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol. 1989;42:597–609
  7. Derry CW, Bourne DE, Sayed AR, et al. Variations in mortality of the coloured, white and Asian population groups in the RSA, 1978–1982. VI. Ischaemic heart disease. S Afr Med J. 1987;72:698–700
  8. Miller GJ, Beckles GL, Maude GH, et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St. James Survey, Trinidad. Int J Epidemiol. 1989;18:808–817
  9. Hughes K, Lun KC, Yeo PP. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Comm Health. 1990;44:24–28
  10. Collins VR, Dowse GK, Cabealawa S, Ram P, Zimmet PZ. High mortality from cardiovascular disease and analysis of risk factors in Indian and Melanesian Fijians. Int J Epidemiol. 1996;25:59–69
  11. Tuomilehto J, Li N, Dowse G, et al. The prevalence of coronary heart disease in the multi-ethnic and high diabetes prevalence population of Mauritius. J Intern Med. 1993;233:187–194
  12. Wild SH, Laws A, Fortmann SP, Varady AN, Byrne CD. Mortality from coronary heart disease and stroke for six ethnic groups in California, 1985–1990. Ann Epidemiol. 1995;5:432–439
  13. Palaniappan L, Wang Y, Fortmann SP. Coronary heart disease mortality for six ethnic groups in California, 1990–2000. Ann Epidemiol. 2004;14:499–506
  14. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000;356:279–284
  15. Lindsay C. Profiles of Ethnic Communities in Canada. The South Asian Community in Canada. Statistics Canada 2001. 2001;1–18Cat. No.89-621-XIE http://www.statcan.ca
  16. Miniño AM, Heron M, Murphy SL, Kochanek KD. Deaths: final data for 2004. Health E-stats. Hyattsville, MD: National Center for Health Statistics; 2006;http://www.cdc.gov/nchs/datawh/statab/unpubd/mortabs.htm
  17. Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics, 2007 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69–171.
  18. Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol. 1992;70:945–949
  19. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601
  20. Reddy KS. Cardiovascular disease in non-western countries. N Engl J Med. 2004;350:2438–2440
  21. Murray CJL, Lopez AD. Global comparative assessments in the health sector. Geneva, Switzerland: World Health Organization; 1994;
  22. Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 2001;38:682–687
  23. Reddy KS. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol. 2007;50:1370–1372
  24. World Health Organization. The World Health Report Preventing Chronic Diseases: A Vital Investment. Geneva: WHO; 2005.
  25. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937–952
  26. Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”?. Am J Hum Genet. 1962;14:353–362
  27. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595–601
  28. Lowry PJ, Lamb P, Watson RD, et al. Influence of racial origin on admission rates of patients with suspected myocardial infarction in Birmingham. Br Heart J. 1991;66:29–35
  29. Robertson TL, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol. 1977;39:239–243
  30. Harding S. Mortality of migrants from the Indian subcontinent to England and Wales: effect of duration of residence. Epidemiology. 2003;14:287–292
  31. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ. 1991;302:560–564
  32. Hughes LO, Raval U, Raftery EB. First myocardial infarctions in Asian and white men. BMJ. 1989;298:1345–1350
  33. Beckles GL, Miller GJ, Kirkwood BR, et al. High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet. 1986;1:1298–1301
  34. Lee J, Heng D, Chia KS, et al. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: The Singapore Cardiovascular Cohort Study. Int J Epidemiol. 2001;30:983–988
  35. Lowry PJ, Glover DR, Mace PJ, Littler W. A Coronary artery disease in Asians in Birmingham. Br Heart J. 1984;52:610–613
  36. Pais P, Pogue J, Gerstein H, et al. Risk factors for acute myocardial infarction in Indians: a case–control study. Lancet. 1996;348:358–363
  37. McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993;87:152–161
  38. Pinto RJ, Bhagwat AR, Loya YS, Sharma S. Coronary artery disease in premenopausal Indian women: risk factors and angiographic profile. Indian Heart J. 1992;44:99–101
  39. Enas EA, Garg A, Davidson MA, et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48:343–353
  40. Agyemang C, Bhopal RS. Is the blood pressure of South Asian adults in the UK higher or lower than that in European white adults? A review of cross-sectional data. J Hum Hypertens. 2002;16:739–751
  41. Agyemang C, Bhopal R, Bruijnzeels M, Redekop WK. Does the white-coat effect in people of African and South Asian descent differ from that in White people of European origin? A systematic review and meta-analysis. Blood Press Monit. 2005;10:243–248
  42. Deedwania PC, Gupta R. In:  Izzo JL,  Black HR editor. Hypertension in South Asians. hypertension primer. 3rd edn.. Philadelphia: Lippincott, Williams and Wilkins; 2003;
  43. Yancy C. In:  Libby P,  Bonow RO,  Mann DL,  Zipes DP editor. Heart disease in varied populations. Braunwald’s heart disease. A textbook of cardiovascular medicine. 8th edn.. Philadelphia: Elsevier; 2008;p. 32
  44. Enas EA. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 1995;92:2353–2354
  45. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382–386
  46. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet. 1995;345:405–409
  47. Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol. 1999;19:2749–2755
  48. Krauss RM. Dense low-density lipoproteins and coronary artery disease. Am J Cardiol. 1995;75:53B–57B
  49. Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917–1921
  50. Lamarche B, Tchernof A, Moorjani S, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation. 1997;95:69–75
  51. Watts GF, Mandalia S, Brunt JN, et al. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas’ Atherosclerosis Regression Study (STARS). Metabolism. 1993;42:1461–1467
  52. Galeano NF, Al-Haideri M, Keyserman F, Rumsey SC, Deckelbaum RJ. Small dense low-density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res. 1998;39:1263–1273
  53. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart. 1997;78:555–563
  54. Unwin N, Alberti KG, Bhopal R, et al. Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. American Diabetes Association. Diabet Med. 1998;15:554–557
  55. Bhopal R, Unwin N, White M, et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross-sectional study. BMJ. 1999;319:215–220
  56. Anand SS, Yusuf S. Risk factors for cardiovascular disease in Canadians of South Asian and European origin: a pilot study of the Study of Heart Assessment and Risk in Ethnic Groups (SHARE). Clin Invest Med. 1997;20:204–210
  57. Venkataraman R, Nanda NC, Baweja G, Parikh N, Bhatia V. Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States. Am J Cardiol. 2004;94:977–980
  58. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998;21:518–524
  59. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23:1278–1283
  60. Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia. 2006;49:2580–2588
  61. Chaturvedi N, Fuller JH. Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes?. J Epidemiol Comm Health. 1996;50:137–139
  62. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med. 1998;15:53–59
  63. Radha V, Vimaleswaran KS, Babu HN, et al. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity. Diabetes Care. 2006;29:1046–1051
  64. Abate N, Carulli L, Cabo-Chan A, et al. Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab. 2003;88:5927–5934
  65. Johnson M. Perceptions of barriers to healthy physical activity among Asian communities. Sport Educ Soc. 2000;5:151–170
  66. Hayes L, White M, Unwin N, et al. Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population. J Public Health Med. 2002;24:170–178
  67. Jacobson MS. Cholesterol oxides in Indian ghee: possible cause of unexplained high risk of atherosclerosis in Indian immigrant populations. Lancet. 1987;2:656–658
  68. Shankar SR, Bijlani RL, Baveja T, et al. Effect of partial replacement of visible fat by ghee (clarified butter) on serum lipid profile. Indian J Physiol Pharmacol. 2002;46:355–360
  69. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart. 2003;89:681–686
  70. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome 2005 http://www.idf.org/home.
  71. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–480
  72. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–2716
  73. Ajjan R, Carter AM, Somani R, Kain K, Grant PJ. Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemostasis. 2007;5:754–760
  74. Gupta M. NCEP and WHO definitions are equally Predictive of metabolic syndrome in South Asians but not in European Canadians with coronary disease: findings from the PRACITCE registry. Can J Cardiol. 2004;20(Suppl. D):500
  75. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003;60:199–204
  76. Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol. 2007;36:220–225
  77. Yusuf S, et al. INTERHEART Study Investigators Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet. 2005;366:1640–1649
  78. Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86:5366–5371
  79. Snehalatha C, Viswanathan V, Ramachandran A. Cut-off values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26:1380–1384
  80. WHO Expert Consultation . Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163
  81. Grundy SM, et al. American Heart Association, National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  82. Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA. 1996;276:544–548
  83. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest. 1992;89:1040–1046
  84. Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297:286–294
  85. Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S. Elevated lipoprotein(a) levels in South Asians in North America. Metabolism. 1998;47:182–184
  86. Renges HH, Wile DB, McKeigue PM, Marmot MG, Humphries SE. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis. 1991;91:267–275
  87. Hoogeveen RC, Gambhir JK, Gambhir DS, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res. 2001;42:631–638
  88. Dhawan J, Bray CL. Relationship between angiographically assessed coronary artery disease, plasma insulin levels and lipids in Asians and Caucasians. Atherosclerosis. 1994;105:35–41
  89. Sharobeem KM, Patel JV, Ritch AE, et al. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke. Int J Clin Pract. 2007;61:1824–1828
  90. Forouhi NG, Rumley A, Lowe GD, McKeigue P, Sattar N. Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans. Blood Coagul Fibrin. 2003;14:755–760
  91. (a)Raji A, Gerhard-Herman MD, Warren M, et al. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab. 2004;89:3965–3972(b)Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288:H2031–H2041
  92. Murphy C, Kanaganayagam GS, Jiang B, et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol. 2007;27:936–942
  93. Pearson TA, et al. Centers for Disease Control and Prevention, American Heart Association Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511
  94. Mazer SP, Rabbani LE. Evidence for C-reactive protein’s role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP. J Thromb Thrombolysis. 2004;17:95–105
  95. Chambers JC, Eda S, Bassett P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation. 2001;104:145–150
  96. Anand SS, Razak F, Yi Q, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol. 2004;24:1509–1515
  97. Chandalia M, Cabo-Chan AV, Devaraj S, et al. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab. 2003;88:3773–3776
  98. Patel JV, Vyas A, Cruickshank JK, et al. Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis. 2006;185:297–306
  99. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639
  100. Johansson J, Carlson LA, Landou C, Hamsten A. High-density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb. 1991;11:174–182
  101. Bhalodkar NC, Blum S, Rana T, et al. Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol. 2004;94:1561–1563
  102. Bedi US, Singh S, Syed A, Aryafar H, Arora R. Coronary artery disease in South Asians: an emerging risk group. Cardiol Rev. 2006;14:74–80
  103. Gupta M, Singh N, Warsi M, Reiter M, Ali K. Canadian South Asians have more severe angiographic coronary disease than European Canadians despite having fewer risk factors. Can J Cardiol. 2001;17(Suppl. C):226C
  104. Dhawan J, Bray CL. Are Asian coronary arteries smaller than Caucasian? A study on angiographic coronary artery size estimation during life. Int J Cardiol. 1995;49:267–269
  105. Brister SJ, Hamdulay Z, Verma S, Maganti M, Buchanan MR. Ethnic diversity: South Asian ethnicity is associated with increased coronary artery bypass grafting mortality. J Thorac Cardiovasc Surg. 2007;133:150–154
  106. South Asian Health Foundation Consensus Statement 2006. Dyslipidemia management in South Asians. 2006. Available at http://www.sahf.org.uk/Version_9_SAHF_statement.pdf (accessed September 13, 2007).
  107. Aarabi M, Jackson PR. Predicting coronary risk in UK South Asians: an adjustment method for Framingham-based tools. Eur J Cardiovasc Prev Rehabil. 2005;12:46–51
  108. Deedwania PC, Gupta M, Stein M, Ycas J, Gold A. Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial). Am J Cardiol. 2007;99:1538–1543

PII: S0021-9150(08)00678-3

doi: 10.1016/j.atherosclerosis.2008.09.023

Atherosclerosis
Volume 204, Issue 1 , Pages 1-10 , May 2009

Article Tools

* Image Usage & Resolution